Rising prevalence of bacterial vaginosis, and the increased focus on developing novel and targeted therapies are contributing to the growing bacterial vaginosis drug market size. However, the high recurrence rate and treatment adherence challenges hampers the bacterial vaginosis drug market growth. Further, rising inclination toward microbiome therapies and probiotics are expected to bring in new […]